Answers are grounded in this paper and cite their sources.
BACKGROUND: Influenza B viruses are important contributors to seasonal influenza epidemics. Two antigenically distinct lineages, B/Victoria and B/Yamagata, have been circulating since the late 1980s. However, the B/Yamagata lineage has not been detected in most countries since 2020, potentially resulting in waning immunity that may leave people vulnerable to B/Yamagata virus infections, should this lineage reemerge. METHODS: We investigated the impact of the recent lack of B/Yamagata virus circulation on immunity in adults by analyzing the hemagglutination-inhibition (HI) titers of serum samples (n = 504) collected from 2013 through 2024 against influenza B viruses circulating from 1958 to 2019. RESULTS: Human serum HI titers to B/Yamagata viruses have not markedly declined since B/Yamagata viruses were last detected in the US in 2020. Human serum HI titers were highest against the first encountered B/Victoria- and B/Yamagata-lineage viruses, respectively, revealing imprinting effects. CONCLUSIONS: The recent disappearance of the B/Yamagata lineage has not led to a substantial decline in antibody levels against this lineage.
No takes yet. Share an insight, caveat, or question.
Abozeid et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: